Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients - A randomized controlled study

Pharmacological Reports

Volumn 66, Issue 1, 2014, Pages 44-48

  Rajanandh, Muhasaparur Ganesan ^a   Kosey, Sourabh ^a   Prathiksha, Giridharan ^b  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Antioxidant; Diabetic neuropathy; Quality of life; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PREGABALIN; PREGANERVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; BEDTIME DOSAGE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NEUROPATHY PAIN SCORE; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE; RAND 36; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TERTIARY CARE CENTER; VITAMIN SUPPLEMENTATION; DIABETIC NEUROPATHIES; DIET SUPPLEMENTATION; MIDDLE AGED; NEURALGIA; PATHOPHYSIOLOGY; PSYCHOLOGY;

ADULT; AGED; ANTIOXIDANTS; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; QUALITY OF LIFE; VITAMIN E;

EID: 84899624477     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2013.08.003     Document Type: Article

References (33)

1. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid. The SYDNEY trial. Diabetes Care 2003;26:770-66P
2. Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, et al. National data on diabetes, ICMR study. INDIAB 2009;23:991-66P
3. Bascil T, Bayraktar, Varli. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes. Diabetes Care 1998;21:1915-86P
4. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. J Med 1998;91:733-76P
5. Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. J Am Med Assoc 1998;280:1831-66P
6. Boulton AJ, Knight G, Drury J, Ward JD. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population. Diabetes Care 1985;8:125-86P
7. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies. A statement by the American Diabetes Association. Diabetes Care 2005;28:956-626P
8. Cruccu G, Truini A. Tools for assessing neuropathic pain. PLoS Med 2009;6:1-56P
9. Galer BS, Jensen MP, Tina MA, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002;18:297-3016P
10. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathy pain: the neuropathic pain scale. Neurology 1997;48:332-86P
11. Hartemann A, Attal N, Bouhassira D, Dumont I, Gin H, Jeanne S, et al. Painful diabetic neuropathy: diagnosis and management. Diabetes Metab 2011;37:377-886P
12. Ide H, Fujiya S, Asanuma Y, Tsuji M, Sakai H, Agishi Y. Clinical useful of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clin Ther 1987;9:183-926P
13. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007;68:1178-826P
14. Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. Q J Med 2008;101:685-956P
15. Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999;38:472-56P
16. Maneesh A, Deshpande, Ronald Holden R, Gilron I
17. Mckinlay J, Marceau L. US public health and the 21st century: diabetes mellitus. Lancet 2000;93:191-66P
18. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression and sleep. J Pain Symptom Manage 2005;30:374-8856P
19. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabetes Med 2002;19:870-36P
20. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patient with non-insulin dependent diabetes mellitus. N Engl J Med 1995;333:89-946P
21. Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetic complications. Mech Ageing Dev 2010;131:276-866P
22. Phillips CA, Molitch ME. The relationship between glucose control and the development and progression of diabetic neuropathy. Curr Diab Rep 2002;2(6):532-96P
23. Pourmand R. Diabetic neuropathy. Neurol Clin 1997;15(3):569-766P
24. Rog DJ, Nurmikko TJ, Friede T, Young CA. Validation and reliability of the neuropathic pain scale in multiple sclerosis. Clin J Pain 2007;23(6):473-816P
25. Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Micro vascular perfusion abnormalities of the thalamus in painful but not painless diabetic polyneuropathy. Diabetes Care 2011;34(3):718-20.
26. Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-4006P
27. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007;23(2):143-96P
28. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593-6006P
29. Vijayakumar APR, Jayesh BK, Jenny VM, Sushanta DK. Supplementation of vitamin E improves cognitive status and oxidative stress function in type 2 diabetes mellitus. Int Res J Pharm 2011;2(11):169-726P
30. Vileikyte L, Rubin RR, Leventhal H. Psychological aspect of diabetic neuro-pathic foot complication: an overview. Diabetes Metab Res Rev 2004;20: s13-86P
31. Vinik A, Fonseca V, LaMoreaux L, Hes M, Koto K. Neurontin (gabapentin, GBP) improves quality of life (QOL) in patients with painful diabetic peripheral neuropathy. Diabetes 1998;47(Suppl. 1):A3746P
32. Yaqub BA, Siddique A, Sulimani R. Effect of methylcobalamine on diabetic neuropathy. Clin Neurol Neurosurg 1992;94(2):105-116P
33. Ziegler D, Gries FA, Spuler M, Lessmann F. The epidemiology of diabetic neuropathy. J Diabetes Complications 1992;6:49-57.6P6P (Pubitemid 23034751)